Wayne Backes          

wayne backes

Research Interests

Project 1 – Organization and Complex Formation among Multiple Cytochrome P450 Enzymes in the Endoplasmic Reticulum – Cytochrome P450 enzymes are responsible for the metabolism of virtually every foreign compound that enters an organism. The major function of the P450 system is to carry out oxidation reactions, usually by hydroxylation of the substrate.  Most of these reactions lead to products/intermediates that are more water-soluble and consequently more rapidly excreted.  However, some products are reactive, capable of binding to biological macromolecules, an initial step leading to carcinogenesis. 
P450 enzymes do not act independently, but require formation of a 1:1 complex with the flavoprotein NADPH-P450 reductase (reductase), which transfers electrons to P450.  Because P450 exists in a large excess over reductase in vivo, the P450 enzymes must effectively compete for the reductase or be metabolically silent.  The goal of this project is to examine the organization of multiple P450 enzymes and NADPH-cytochrome P450 reductase in the membrane, and to determine the potential for the formation of P450-P450 complexes that can influence the function of these enzymes.  The studies include characterization of these interactions, identification of the contact points among the proteins, and determination of their effects on metabolism of hydrocarbons, carcinogens, and other foreign compounds.

Project 2 – How do Heme Oxygenase, Cytochrome P450 their Electron Transfer Partners Interact in the Endoplasmic Reticulum – Heme oxygenase (HO) has been reported to play a complex role in both cytoprotection and carcinogenesis.  HO catalyzes the breakdown of heme to biliverdin, iron, and carbon monoxide (CO).  HO also uses NADPH-P450 reductase as its source of electrons, suggesting that both P450 and HO may compete for the reductase in order to function.  The interactions among these proteins could affect the initial mutations that lead to cancer through the P450 system, or could modulate protection of the cell through the heme oxygenase system.  Because the full length form is unstable, most studies with HO have used a form where the membrane binding region of the protein is missing.  Unfortunately, this does not allow HO to associate with the membrane as occurs in vivo.  We recently generated a stable form of HO that is able to bind to the membrane.  The goal of these experiments is to better understand how reductase, P450 and HO-1 interact within a membrane environment.  This will be accomplished by measuring the catalytic effectiveness of each of these proteins both separately and in combination. 


Related publications:

  1. Backes, W.L. and Kelley, R.W. (2003) Organization of Multiple Cytochrome P450s and NADPH-cytochrome P450 Reductase in Lipid Membranes, Pharmacol. Ther., 98, 221-233.
  2. Cheng, Dongmei, Kelley, R.W., Cawley, G.F., and Backes, W.L.  (2004) High Level Expression of Recombinant Rabbit Cytochrome P450 2E1 in Escherichia coli C41 and Its Purification.  Prot. Express. Purific. 33, 66-71.
  3. Kelley, R.W., Reed, J.R. and Backes, W.L. (2005) Effects of Ionic Strength on the Functional Interactions between CYP2B4 and CYP1A2.  Biochemistry, 44, 2632-2641.
  4. Backes, W.L., Kelley, R.W., Cheng, D., and Reed, J.R. (2005) How are NADPH-cytochrome P450 Reductase and Multiple Cytochromes P450 Organized in Membranes?  Proceedings from the 14th International Conference on Cytochrome P450: Biochemistry, Biophysics and Bioinformatics 163-170.
  5. Reed, J.R., Kelley, R.W., and Backes, W.L.  (2006) An Evaluation of Methods for the Reconstitution of Cytochromes P450 and NADPH P450 Reductase into Lipid Vesicles.  Drug Metab. Dispos. 34, 660-666.
  6. Cormier, S.A., Lomnicki, S., Backes, W., and Dellinger, B. (2006) Origin and Health Impacts of Emissions of Toxic By-Products and Fine Particles from Combustion and Thermal Treatment of Hazardous Wastes and Materials. Environmental Health Persp. 114, 1-10.
  7. Kelley, R.W., Cheng, D., and Backes, W.L. (2006) Heteromeric Complex Formation Between CYP2E1 and CYP1A2: Evidence for the Involvement of Electrostatic Interactions. Biochemistry 45, 15807-15816.
  8. Cheng, D., Reed, J.R. Harris, D., and Backes, W.L. (2007) Inhibition of CYP2B4 by the Mechanism-based inhibitor 2-Ethynylnaphthalene: Inhibitory Potential of 2EN is Dependent on Substrate Size. Arch. Biochem. Biophys. 462, 28-37.
  9. Cheng, D., Harris, D., Reed, J.R. and Backes, W.L. (2007) Inhibition of CYP2B4 by the Mechanism-based inhibitor 2-Ethynylnaphthalene: Evidence for the Co-Binding of Substrate and Inhibitor within the Active Site. Arch. Biochem. Biophys. 468, 174-182.
  10. Huber, W.J. and Backes, W.L. (2007) Expression and Characterization of Full-Length Human Heme Oxygenase-1: Presence of intact membrane-binding region leads to increased binding affinity for NADPH-cytochrome P450 reductase. Biochemistry 46, 12212-12219.
  11. Huber, W.J. and Backes, W.L. (2008) Quantitation of Heme Oxygenase-1: Heme Titration Increases Yield of Purified Protein, Anal. Biochem. 373, 167-169.
  12. Reed, J.R., Brignac-Huber, L.M., Backes, W.L. (2008) Physical Incorporation of NADPH-cytochrome P450 Reductase and Cytochrome P450 into Phospholipid Vesicles using Glycocholate and Biobeads. Drug Metab. Dispos. 36, 582–588.

Contact: wbacke@lsuhsc.edu